Custom Search

Brand Name(s): Epivir; Epivir-HBV
CAS nº: 134678-17-4
(la mih vue deen)

What is Lamivudine?

Lamivudine is an antiviral medication. It is in a group of human immunodeficiency virus (HIV) medicines called reverse transcriptase inhibitors. Lamivudine helps keep the HIV virus from reproducing in the body.

The Epivir® brand of lamivudine is used to treat HIV and hepatitis B viruses, which cause the acquired immunodeficiency syndrome (AIDS). On the other hand, the Epivir-HBV® brand of lamivudine is used to treat chronic hepatitis B. 

Lamivudine is not, however, a cure for HIV or AIDS.

See more Product Info

Latest News

Low-Dose Tenofovir Shows Efficacy in Patients With Lamivudine-Resistant Hepatitis B Virus: Presented at IM

Virologic breakthrough during hepatitis B virus (HBV) treatment with lamivudine is associated with...

[more]

HIV/AIDS Update - Epivir Tablets for Pediatric Dosing

FDA has approved a new formulation of Epivir (lamivudine) designed to facilitate dosing in...

[more]

What is the more suitable for early detection of low abundant lamivudine-resistant mutants?

Lamivudine is an effective antiviral agent for treatment of patients with chronic hepatitis B and...

[more]

WHO Adds Three Ranbaxy Antiretrovirals to Prequalification List

Indian pharmaceutical company Ranbaxy Laboratories on Monday announced that the World Health...

[more]

Use of this site is subject to the following terms of use